508.58
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$521.11
Offen:
$512.01
24-Stunden-Volumen:
2.05M
Relative Volume:
0.96
Marktkapitalisierung:
$191.08B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
28.67
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
-1.52%
1M Leistung:
-12.58%
6M Leistung:
+4.32%
1J Leistung:
-3.85%
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
TMO
Thermo Fisher Scientific Inc
|
508.58 | 195.79B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
206.00 | 148.95B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
636.70 | 52.44B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
118.17 | 34.33B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
307.23 | 31.33B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Harvest Portfolios Group Inc. Sells 4,403 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Decreased by Huntington National Bank - MarketBeat
Intech Investment Management LLC Sells 5,099 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
How Does Thermo Fisher Scientific Stock Stack Up Against Its Peers? - Trefis
Artisan Partners Limited Partnership Grows Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
The immortal life of Henrietta Lacks lawsuits gets a bit shorter with Novartis settlement - Fortune
Thermo Fisher extends two leases in Middleton - The Daily Reporter
The "Flight to Quality": Thermo Fisher’s Q4 Beat and Dividend Hike Cement Defensive Leadership for 2026 - The Chronicle-Journal
TIAA Trust National Association Buys 7,064 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Xponance Inc. Sells 3,464 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Handelsbanken Fonder AB Boosts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
PCR Technologies Market Is Going to Boom Rapidly | Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd. - openPR.com
Erste Asset Management GmbH Trims Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Stock To $390? - Trefis
Decoding Thermo Fisher Scientific Inc (TMO): A Strategic SWOT In - GuruFocus
Here's What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Finviz
Here’s What Analysts Think About Thermo Fisher Scientific (TMO) Post Earnings - Yahoo Finance
Thermo Fisher Scientific Finalizes $3.8 Billion Senior Notes Offering - Global Legal Chronicle
Did Thermo Fisher’s (TMO) 10% Dividend Hike After Earnings Beat Just Reframe Its Capital Return Story? - simplywall.st
Thermo Fisher Scientific Inc. (NYSE:TMO) Announces Quarterly Dividend of $0.47 - MarketBeat
Westpac Banking Corp Increases Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Introduces New Laboratory Developed Test to Help Transplant Patients Receive the Right Dose of Critical Anti-Rejection Medication Sooner - Business Wire
Precision Medicine Market 2026–2031 Growth: 13%+ CAGR as AI Integration and Biomarker Advancements Drive Adoption, Reports Mordor Intelligence - GlobeNewswire Inc.
Thermo Fisher Scientific (TMO) Boosts Dividend by 10% - GuruFocus
Thermo Fisher Announces 10% Increase in Quarterly Dividend - Intellectia AI
Why Analysts Are Closely Watching Thermo Fisher Scientific Inc. (TMO) - Finviz
Thermo Fisher Scientific Increases Quarterly Dividend - PharmiWeb.com
Thermo Fisher Scientific (TMO) Announces Future Dividend Payment - GuruFocus
Thermo Fisher raises quarterly dividend 10% to $0.47 per share - Investing.com
Thermo Fisher raises quarterly dividend 10% to $0.47 per share By Investing.com - Investing.com South Africa
How Is Thermo Fisher Scientific’s Stock Performance Compared to Other Medical Devices Stocks? - Barchart.com
Thermo Fisher Datavant Deal Deepens Real World Data Role In Trials - Yahoo Finance UK
Scientific Data Management System Market Is Going to Boom - openPR.com
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Magellan Asset Management Ltd - MarketBeat
Digital Cytology Market Is Going to Boom | Roche • Thermo Fisher Scientific • PerkinElmer - openPR.com
Parasitology Market Is Going to Boom | Thermo Fisher Scientific • Merck KGaA • Abbott Laboratories - openPR.com
Thermo Fisher Scientific to Present at Raymond James Annual Institutional Investors Conference - BioSpace
Assessing Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Pullback - simplywall.st
FDA Approved Thermo Fisher Scientific’s (TMO) Oncomine Dx Express Test - MSN
Thermo Fisher Scientific Inc. (TMO) Carries a Mid-Single Digit Organic Growth Forecast - Finviz
Thermo Fisher’s Datavant Data Tie-Up Could Be A Game Changer For Thermo Fisher Scientific (TMO) - Yahoo Finance
How Is The Market Feeling About Thermo Fisher Scientific Inc? - Benzinga
Thermo Fisher CEO to speak at Raymond James investor event - Stock Titan
Innovating Texture and Culture in Plant-Based Foods - News-Medical
Next Generation Sequencing Market Competitive Landscape - GlobeNewswire
Next Generation Sequencing Market Competitive Landscape Report 2025 Featuring Top PlayersThermo Fisher Scientific, Pacific Biosciences, Illumina, Roche - Yahoo Finance
Ion Chromatography Market Is Going to Boom |• Thermo Fisher Scientific • Agilent Technologies - openPR.com
Bioprocessing Reagents Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA - openPR.com
Thermo Fisher Scientific (TMO) Valuation Check As Datavant Data Partnership Draws Fresh Investor Interest - Yahoo Finance
Thermo Fisher boosts connected planning with Oracle Cloud EPM - Oracle
Thermo Fisher-Clario deal open for views in EU - MLex
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):